Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
6,010.00    410.00 (7.32%)
Bid:
5,995.00
Ask:
6,005.00
Spread: 10.00 (0.167%)
Market Cap: $1.58t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Disposition

29 Jan 2026 08:24

RNS Number : 9001Q
Samsung Electronics Co. Ld
29 January 2026
 

Decision on Share Disposition

 

1. Number of shares to be disposed

Common

6,729,069

Other

-

2. Price of shares to be disposed (Korean won)

Common

162,400

Other

-

3. Value of shares to be disposed (Korean won)

Common

1,092,800,805,600

Other

-

4. Expected disposition period

Start date

January 30, 2026

End date

January 30, 2026

5. Purpose of disposition

Use of treasury shares as performance based compensation to employees

6. Method of disposition

Open-market (shares)

-

After-hours block trades (shares)

-

Off-market (shares)

-

Other (shares)

6,729,069

7. Counterparties to the disposition

YoungHyun Jun and 51,669 others

8. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

9. Holding status of treasury shares before disposition

Disposition within the allowable distribution of profit (shares)

Common

107,973,999

Ratio (%)

1.8

Other

13,603,461

Ratio (%)

1.7

Other disposition (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

10. Date of board resolution (confirmation date)

January 28, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

6

Absent

0

- Attendance of Auditors (Audit Committee members who are not Independent Directors)

-

11. Daily sell order quantity limit

Common

-

Other

-

 

 

 

 

 

12. Other Information to Consider:

- This disclosure relates to the use of treasury shares in the agreed amount as part of the 2025 performance-based compensation to align the interests of shareholders and employees. The conditions for the grant and the number of recipients are as follows:

 

(1) 2025 OPI stock-based compensation

[Grant conditions] The number of shares to be granted will be determined based on the agreed upon amount and the market price.(subject to one-year transfer restriction)

[Number of persons eligible for grant] 51,647

 

(2) Individually-agreed LTI stock-based compensation

[Grant conditions] The agreed number of shares will be granted based on the market price at the time of payment

[Number of persons eligible for grant] 80

- The above details are subject to change within the scope approved by the Board, depending on the number of recipients at the time of the grant and changes in the stock price

- In Item 1 above, the number of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 2 above, the price of shares to be disposed (Korean won) is based on the closing price on the day of the Board's resolution (January 28, 2026)

- In Item 3 above, the value of shares to be disposed (Korean won) was calculated by multiplying the number of shares to be disposed by the closing price on the day of board resolution. The actual number of shares disposed of, the stock price, and the total disposal amount may change depending on stock price at the time of disposal.

- In Item 6 above, the method of disposition involves the transfer from the company's treasury account to the accounts of designated employees

- In Item 10 above, all Audit Committee members are Independent Directors (all Audit Committee members were in attendance)

- In Item 11 above, the daily sell order quantity limit is not applicable, as the shares will not be sold through on-market transaction on the securities market

- Holding status of treasury shares before purchase

(Number of shares)

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

17,297,034

1,152,022

-

107,973,999

Other

13,603,461

-

-

-

13,603,461

- The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on January 29, 2026, the day the disclosure document was prepared.

 

Additional disclosure items

1. Relationship to the company or the largest shareholder by each counterparty to transaction

- Employees, etc., of the Company

2. Reason for selecting the counterparty to transaction

- The company agreed to deliver shares upon the payment of 2025 OPI and LTI to align the interests of shareholders and employees and to promote mid-to-long-term growth

3. Number of shares to be disposed of (shrs.) by each counterparty to transaction

- 6,729,069 common shares

4. Price calculation basis

- The number of shares to be disposed in Item 1, the price of shares to be disposed in Item 2 and the value of shares to be disposed in Item 3 were calculated based on the closing price on the day of the Board's resolution (January 28, 2026). However, the actual number of shares disposed of, the stock price, and the total disposal amount may be subject to change

5. Expected dilution

- The number of shares to be disposed in Item 1 above represent approximately 0.114% of the total number of issued shares (5,919,637,922 common), and the dilutive effect on share value is expected to be insignificant

6. Other matters to be factored into investment decisions

 - Of the 6,729,069 shares to be disposed, the number of shares subject to selling restrictions is as follows:

6,596,331 shares subject to a one-year selling restriction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUPPGUPQURB
Date   Source Headline
29th Apr 202012:05 pmRNS2019 Business Report
29th Apr 20207:56 amRNSCharitable Contribution
29th Apr 20207:50 amRNSCharitable Contribution
29th Apr 20207:46 amRNSTransaction with Affiliate Company
29th Apr 20207:43 amRNSTransaction with Affiliate Company
29th Apr 20207:40 amRNSTransaction with Affiliate Company
29th Apr 20207:32 amRNSTransaction with Affiliate Company
29th Apr 20207:28 amRNSQuarterly Dividend for First Quarter 2020
29th Apr 20207:20 amRNS2020 1Q Earnings Release
7th Apr 20207:00 amRNS1Q 2020 Pre-Earnings Guidance
7th Apr 20207:00 amRNSNotice of 1Q 2020 Earnings Release Schedule
18th Mar 20208:35 amRNSTransaction with Affiliate Company
18th Mar 20208:19 amRNSResults of the 51st Annual General Meeting
26th Feb 20208:18 amRNSCharitable Contribution
24th Feb 20208:20 amRNS2019 Consolidated Financial Statements
21st Feb 20209:14 amRNSCharitable Contribution
21st Feb 20208:06 amRNSReference Material for 2020 AGM
30th Jan 20207:00 amRNSYear-End Dividend for FY2019
30th Jan 20207:00 amRNSCharitable Contribution
30th Jan 20207:00 amRNSElectronic Voting
30th Jan 20207:00 amRNS2019 4Q Earnings Release
8th Jan 20207:43 amRNSNotice of 4Q 2019 Earnings Release Schedule
8th Jan 20207:00 amRNS4Q 2019 Pre-Earnings Guidance
29th Nov 20197:49 amRNSTransaction with Affiliate Company
29th Nov 20197:00 amRNSCharitable Contribution
29th Nov 20197:00 amRNS2019 3Q Interim Report
31st Oct 20197:06 amRNSTransaction with Affiliate Company
31st Oct 20197:00 amRNS2019 3Q Earnings Release
31st Oct 20197:00 amRNSQuarterly Dividend for Third Quarter 2019
31st Oct 20197:00 amRNSAnnouncement of Capex Plan for FY 2019
8th Oct 20198:07 amRNSNotice of 3Q 2019 Earnings Release Schedule
8th Oct 20197:00 amRNS3Q 2019 Pre-Earnings Guidance
3rd Sep 201910:12 amRNSCourt Judgment Relating to Embezzlement
30th Aug 20197:24 amRNS2019 Half Year Report
31st Jul 20199:38 amRNSSustainability Report 2019
31st Jul 20198:09 amRNSCharitable Contribution
31st Jul 20198:04 amRNSRenewal of Property & Casualty Insurance Policy
31st Jul 20197:00 amRNS2019 2Q Earnings Release
31st Jul 20197:00 amRNSQuarterly Dividend for Second Quarter 2019
5th Jul 20198:04 amRNSNotice of 2Q 2019 Earnings Release Schedule
5th Jul 20197:00 amRNS2Q 2019 Pre-Earnings Guidance
14th Jun 20197:53 amRNSAnnouncement of Investor Relations Event
7th Jun 20197:00 amRNSRecord Date for Proposed Dividends
3rd Jun 201910:32 amRNSCorporate Governance Report FY2018
3rd Jun 20199:27 amRNSCorporate Governance 2018
31st May 20198:08 amRNS2019 1Q Interim Report
30th Apr 20199:21 amRNS2018 Business Report
30th Apr 20199:14 amRNSCharitable Contribution
30th Apr 20199:11 amRNSCharitable Contribution
30th Apr 20199:06 amRNSTransaction with Affiliate Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.